|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,325.00 JPY | +1.16% |
|
-0.87% | -11.14% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 11,917B 73.36B 64.12B 59.3B 54.41B 103B 7,068B 105B 707B 278B 3,452B 275B 269B | P/E 2026 * |
23.4x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 10,995B 67.68B 59.16B 54.71B 50.2B 95.02B 6,522B 96.67B 652B 256B 3,185B 254B 249B | EV / Sales 2026 * |
7.92x | EV / Sales 2027 * | 7x |
| Free-Float |
38.12% | Yield 2026 * |
1.89% | Yield 2027 * | 2.17% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +1.16% | ||
| 1 week | -0.87% | ||
| Current month | -2.77% | ||
| 1 month | -4.25% | ||
| 3 months | -12.26% | ||
| 6 months | -10.97% | ||
| Current year | -11.14% |
| 1 week | 7,105 |  | 7,350 |
| 1 month | 7,105 | | 7,939 |
| Current year | 7,105 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,871 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Shinya Takuma
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Fumio Tateishi
BRD | Director/Board Member | 77 | 01/03/2023 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
Hideo Teramoto
BRD | Director/Board Member | 66 | 01/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.16% | -0.87% | +5.85% | +87.44% | 73.36B | |
| +1.08% | -3.93% | +48.03% | +160.13% | 1,043B | |
| +1.19% | -3.52% | +51.70% | +56.36% | 602B | |
| +4.21% | +1.79% | +33.48% | +87.04% | 449B | |
| +0.66% | -0.48% | +30.35% | +24.91% | 327B | |
| +1.01% | +0.55% | +33.88% | +47.15% | 279B | |
| -0.62% | -2.06% | +21.90% | +23.24% | 264B | |
| +3.70% | +2.19% | +24.27% | +63.38% | 201B | |
| +3.49% | +1.08% | +24.08% | +76.58% | 169B | |
| +1.29% | +3.67% | +2.15% | -30.78% | 143B | |
| Average | +0.91% | -0.78% | +27.57% | +59.54% | 355.04B | |
| Weighted average by Cap. | +0.65% | -1.81% | +36.92% | +83.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.54B 7.47B 6.9B 6.34B 11.99B 823B 12.2B 82.33B 32.34B 402B 32.07B 31.37B | 1,535B 9.45B 8.26B 7.64B 7.01B 13.27B 911B 13.5B 91.1B 35.79B 445B 35.49B 34.71B |
| Net income | 509B 3.13B 2.74B 2.53B 2.32B 4.4B 302B 4.47B 30.2B 11.86B 147B 11.76B 11.51B | 593B 3.65B 3.19B 2.95B 2.71B 5.12B 352B 5.21B 35.18B 13.82B 172B 13.7B 13.4B |
| Net Debt | -922B -5.68B -4.96B -4.59B -4.21B -7.97B -547B -8.11B -54.71B -21.49B -267B -21.31B -20.84B | -1,164B -7.17B -6.26B -5.79B -5.32B -10.06B -690B -10.23B -69.08B -27.14B -337B -26.91B -26.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | ¥7,325.00 | +1.16% | 2,964,200 |
| 16/07/26 | ¥7,241.00 | +1.59% | 2,301,400 |
| 15/07/26 | ¥7,128.00 | -1.56% | 2,330,400 |
| 14/07/26 | ¥7,241.00 | +0.15% | 1,973,600 |
| 13/07/26 | ¥7,230.00 | -2.15% | 2,054,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
